EVOKE PHARMA INC's ticker is EVOK and the CUSIP is 30049G104. A total of 28 filers reported holding EVOKE PHARMA INC in Q1 2021. The put-call ratio across all filers is 0.16 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2020 | $78,000 | -45.1% | 30,260 | 0.0% | 0.00% | -50.0% |
| Q3 2020 | $142,000 | +32.7% | 30,260 | 0.0% | 0.00% | +33.3% |
| Q2 2020 | $107,000 | +224.2% | 30,260 | +7.1% | 0.00% | +200.0% |
| Q1 2020 | $33,000 | +50.0% | 28,260 | +108.4% | 0.00% | 0.0% |
| Q4 2019 | $22,000 | +144.4% | 13,560 | +35.6% | 0.00% | – |
| Q3 2019 | $9,000 | – | 10,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Wambolt & Associates, LLC | 32,000 | $113,000 | 0.09% |
| Cetera Advisor Networks LLC | 30,260 | $107,000 | 0.00% |
| Creative Planning | 100,000 | $354,000 | 0.00% |
| OPTIMUM INVESTMENT ADVISORS | 800 | $3,000 | 0.00% |
| Lindbrook Capital, LLC | 1,000 | $4,000 | 0.00% |
| NORTHERN TRUST CORP | 37,438 | $133,000 | 0.00% |
| CONCOURSE FINANCIAL GROUP SECURITIES, INC. | 0 | $0 | 0.00% |
| GEODE CAPITAL MANAGEMENT, LLC | 188,514 | $667,000 | 0.00% |
| CITIGROUP INC | 500 | $2,000 | 0.00% |
| GOLDMAN SACHS GROUP INC | 35,174 | $125,000 | 0.00% |